| An Integrated encyclopedia of DNA elements in the human genome TEP Consortium Nature 489 (7414), 57-74, 2012 | 18945 | 2012 |
| Integrative clinical genomics of advanced prostate cancer D Robinson, EM Van Allen, YM Wu, N Schultz, RJ Lonigro, JM Mosquera, ... Cell 161 (5), 1215-1228, 2015 | 4385 | 2015 |
| The molecular taxonomy of primary prostate cancer A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ... Cell 163 (4), 1011-1025, 2015 | 3086 | 2015 |
| Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer H Beltran, D Prandi, JM Mosquera, M Benelli, L Puca, J Cyrta, C Marotz, ... Nature medicine 22 (3), 298-305, 2016 | 1838 | 2016 |
| Organoid cultures derived from patients with advanced prostate cancer D Gao, I Vela, A Sboner, PJ Iaquinta, WR Karthaus, A Gopalan, ... Cell 159 (1), 176-187, 2014 | 1772 | 2014 |
| Punctuated evolution of prostate cancer genomes SC Baca, D Prandi, MS Lawrence, JM Mosquera, A Romanel, Y Drier, ... Cell 153 (3), 666-677, 2013 | 1590 | 2013 |
| A user’s guide to the encyclopedia of DNA elements (ENCODE) ENCODE Project Consortium PLoS Biol 9 (4), e1001046, 2011 | 1553 | 2011 |
| The genomic complexity of primary human prostate cancer MF Berger, MS Lawrence, F Demichelis, Y Drier, K Cibulskis, ... Nature 470 (7333), 214-220, 2011 | 1517 | 2011 |
| Genomic correlates of clinical outcome in advanced prostate cancer W Abida, J Cyrta, G Heller, D Prandi, J Armenia, I Coleman, M Cieslik, ... Proceedings of the National Academy of Sciences 116 (23), 11428-11436, 2019 | 1480 | 2019 |
| Integrative Analysis of the Caenorhabditis elegans Genome by the modENCODE Project MB Gerstein, ZJ Lu, EL Van Nostrand, C Cheng, BI Arshinoff, T Liu, ... Science 330 (6012), 1775-1787, 2010 | 1208 | 2010 |
| Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets H Beltran, DS Rickman, K Park, SS Chae, A Sboner, TY MacDonald, ... Cancer discovery 1 (6), 487-495, 2011 | 1137 | 2011 |
| Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine C Pauli, BD Hopkins, D Prandi, R Shaw, T Fedrizzi, A Sboner, V Sailer, ... Cancer discovery 7 (5), 462-477, 2017 | 1071 | 2017 |
| The long tail of oncogenic drivers in prostate cancer J Armenia, SAM Wankowicz, D Liu, J Gao, R Kundra, E Reznik, ... Nature genetics 50 (5), 645-651, 2018 | 961 | 2018 |
| Assessment of transcript reconstruction methods for RNA-seq T Steijger, JF Abril, PG Engström, F Kokocinski, TJ Hubbard, R Guigó, ... Nature methods 10 (12), 1177-1184, 2013 | 823 | 2013 |
| Suppression of insulin feedback enhances the efficacy of PI3K inhibitors BD Hopkins, C Pauli, X Du, DG Wang, X Li, D Wu, SC Amadiume, ... Nature 560 (7719), 499-503, 2018 | 740 | 2018 |
| The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer D Chakravarty, A Sboner, SS Nair, E Giannopoulou, R Li, S Hennig, ... Nature communications 5 (1), 5383, 2014 | 661 | 2014 |
| N-Myc induces an EZH2-mediated transcriptional program driving neuroendocrine prostate cancer E Dardenne, H Beltran, M Benelli, K Gayvert, A Berger, L Puca, J Cyrta, ... Cancer cell 30 (4), 563-577, 2016 | 642 | 2016 |
| PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors W Lee, S Teckie, T Wiesner, L Ran, CN Prieto Granada, M Lin, S Zhu, ... Nature genetics 46 (11), 1227-1232, 2014 | 641 | 2014 |
| Novel YAP1‐TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma CR Antonescu, F Le Loarer, JM Mosquera, A Sboner, L Zhang, CL Chen, ... Genes, Chromosomes and Cancer 52 (8), 775-784, 2013 | 616 | 2013 |
| The real cost of sequencing: higher than you think! A Sboner, XJ Mu, D Greenbaum, RK Auerbach, MB Gerstein Genome biology 12 (8), 125, 2011 | 548 | 2011 |
Mark A RubinProfessor & Director Department for BioMedical Research, University of BernVerified email at dbmr.unibe.ch
